Participate in Substance Use studies at VCHRI.
The purpose of this study is to evaluate the efficacy of 25mg of psilocybin versus a placebo in subjects with alcohol use disorder through analysis of the number of heavy drinking days over the eight-week treatment period.
The purpose of this study is to measure patterns of hepatitis C virus (HCV) reinfection after achieving an undetectable viral load at end of treatment on direct-acting aniviral therapy; to determine the threshold of risk reduction practices that protects against HCV reinfection after achieving an undetectable viral load; and to evaluate the potential impact of successful HCV treatment in terms of health care costs and resource utilization.
The purpose of this study is to investigate the effects of cannabis in people who use recreational cannabis and meet criteria for heavy drinking. Investigators will examine the emotional and cognitive effects of cannabis oil on social and cognitive functioning.
The purpose of this study is to provide real-life evidence for the role of community-based, low-barrier, short-stay facilities in providing care for patients struggling with substance use disorder and severe bacterial infection requiring a prolonged (approximately 2-6 week) course of antibiotics.
The purpose of this study is to assess whether a phone texting service will improve quality of care provided to the patients discharged from the Joseph & Rosalie Segal Family Health Centre at Vancouver General Hospital. Providing additional support, via their mobile phones, and connection to a care navigator, especially after discharge from psychiatric inpatient units may help patients make a seamless transition from hospital to community-based care and can potentially reduce losses to follow-up and unplanned readmissions to hospital.
The purpose of this study is to determine the lung and immune function benefits of stopping vaping for 72 hours in young adults who use e-cigarettes containing nicotine. The study also aims to determine if telling participants of their own personalized changes to their lung and immune function following the 72 hour abstinence period affects their motivation in quitting vaping.